With the change of social model and the improvement of living conditions, the base of obesity patients is getting larger and larger, and the market of weight loss products is getting larger and larger, then, what are the weight loss drugs currently available? Weight loss drugs that has been approved Weight loss drugs that have been approved include but are not …
In bodybuilding, we often see multiple supplements being used in stack use in the expectation of gaining more. In weight loss, actually, there’s not much stack use. On Retatrutide, however, we often see stack users. Why? Retatrutide stack status For Semaglutide, the individual users we see are basically only using Semaglutide, and rarely see stack. For Tirzepaptide, most of them …
Many people who use Semaglutide to lose weight will find that on Semaglutide, you may completely lose your appetite to eat, and even reach the point of nausea at the sight of food, so in this case, how to ensure the intake of protein and fiber? Why we have to ensure protein and fiber intake? What is protein and its …
Glucagon-like peptide-1 (GLP-1) is a hormone for regulating blood sugar levels and appetite. In recent years, GLP-1 receptor agonists have received a lot of attention for their dual role in treating type 2 diabetes and promoting weight loss. In this paper, we’ll discuss the mechanism of action, benefits and dosage guidelines of GLP-1 receptor agonists in depth. Understand GLP-1 GLP-1 …
Semaglutide is a GLP-1 single receptor agonist, Tirzpatide is a GLP-1 and GIP double receptor agonist, and Retatrutide is a GLP-1, GIP and GCG triple receptor agonist. From their mode of action, we would think that there is a progressive relationship between them. If there is a progressive relationship between modes of action, does that mean there is also a …
No matter what age you are, once you talk about weight loss, there is always a lot of resonance, especially among women. Here are some weight loss tips for your information if you are interested in it. Make a weight loss plan After making up your mind to lose weight, just relying on the consciousness to keep telling yourself to …
Losing weight is a very simple thing. Quit drinking, improve diet, exercise more. It doesn’t get any more complicated than that. It’s really no more complicated than that unless you have medical issues or disability. Losing weight can be hard if you can’t be strict with yourself. Quit drinking “Quit drinking alcohol and soda, exercised 30-1hr most days of the …
Many people are concerned about the latest weight loss product Retatrutide, and some people are already using it to lose weight. However, Retatrutide is still a drug under trials, so why buy it for weight loss? Weight loss effects of Retatrutide As a three-receptor agonist, Retatrutide’s weight loss effect was demonstrated in its Phase 2 trial. After 48 weeks of …
The three most widely talked about peptides are Semaglutide, Tirzepatide and Retatrutide. Of the three peptides, Semalutide is the most widely used weight loss peptide, while Retatrutide is the latest. Today, let’s compare these three peptides. Semaglutide Tirzepatide Retatrutide Working mechanism Semaglutide is a GLP-1 receptor agonist;The GLP-1 in Semaglutide shares 94% similarity with the human body and has a …
Losing weight can be said to be one of the most popular topics in contemporary society. Some people lose weight for an attractive appearance, while others lose weight for a healthier body. The two most common ways to lose weight are to control your diet and participate in exercise. These two ways can help lose weight, but after the weight …
Peptides Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist. What is GLP-1? GLP-1, or glucagon-like peptide-1, is a hormone that naturally producing in the body. It mainly produce in the gut. GLP-1 plays a crucial role in regulating blood sugar levels and appetite. In consuming food, GLP-1releasing into the blood, and it has several effects on the body. Stimulates …
Rybelsus (Main including Semaglutide and SNAC) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes on September 20, 2019. Rybelsus, developed by A Danish pharmaceutical company and Nord Ag, is the first drug approved in the United States for glucagon-like peptide-1 (GLP-1) receptor protein that does not require an injection. …